Literature DB >> 6719456

Protection by silibinin against Amanita phalloides intoxication in beagles.

G Vogel, B Tuchweber, W Trost, U Mengs.   

Abstract

A single oral dose of the lyophilized deathcap fungus Amanita phalloides (85 mg/kg body wt) caused gastrointestinal signs of diarrhea, retching, and vomiting in beagles after a latent period of 16 hr. The pathologic lesions; the increases in serum transaminase (GOT, GPT), alkaline phosphatase, and bilirubin, as well as the fall in prothrombin time all indicated that liver damage was maximal at about 48 hr after poisoning. Four of twelve dogs given A. phalloides died with signs of hepatic coma within 35 to 54 hr with the biochemical values in the survivors reverting to normal by the ninth day. Silibinin administration (50 mg/kg) 5 and 24 hr after intoxication suppressed the serum changes and the fall in prothrombin time. The degree of hemorrhagic necrosis in the liver was markedly reduced, and none of the silibinin-treated dogs died.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6719456     DOI: 10.1016/0041-008x(84)90087-5

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  12 in total

1.  Mushroom Poisoning.

Authors:  Salil Garg; Vasu Vardhan; S C Sood
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 2.  The use of selected nutrition supplements and complementary and alternative medicine in liver disease.

Authors:  A James Hanje; Brett Fortune; Ming Song; Daniell Hill; Craig McClain
Journal:  Nutr Clin Pract       Date:  2006-06       Impact factor: 3.080

Review 3.  Is there any use for nontraditional or alternative therapies in patients with chronic liver disease?

Authors:  N M Bass
Journal:  Curr Gastroenterol Rep       Date:  1999 Feb-Mar

Review 4.  [Mushroom poisonings: syndromic diagnosis and treatment].

Authors:  Peter Kaufmann
Journal:  Wien Med Wochenschr       Date:  2007

5.  In vitro mechanistic studies on α-amanitin and its putative antidotes.

Authors:  Daniela Ferreira Rodrigues; Ricardo Pires das Neves; Alexandra T P Carvalho; Maria Lourdes Bastos; Vera M Costa; Félix Carvalho
Journal:  Arch Toxicol       Date:  2020-03-19       Impact factor: 5.153

Review 6.  Polyphenols and gastrointestinal diseases.

Authors:  Gerald W Dryden; Ming Song; Craig McClain
Journal:  Curr Opin Gastroenterol       Date:  2006-03       Impact factor: 3.287

7.  A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis.

Authors:  Samer S El-Kamary; Michelle D Shardell; Mohamed Abdel-Hamid; Soheir Ismail; Mohamed El-Ateek; Mohamed Metwally; Nabiel Mikhail; Mohamed Hashem; Amr Mousa; Amr Aboul-Fotouh; Mohamed El-Kassas; Gamal Esmat; G Thomas Strickland
Journal:  Phytomedicine       Date:  2009-03-19       Impact factor: 5.340

Review 8.  Legalon® SIL: the antidote of choice in patients with acute hepatotoxicity from amatoxin poisoning.

Authors:  Ulrich Mengs; Ralf-Torsten Pohl; Todd Mitchell
Journal:  Curr Pharm Biotechnol       Date:  2012-08       Impact factor: 2.837

9.  Unconventional application of the Mitsunobu reaction: Selective flavonolignan dehydration yielding hydnocarpins.

Authors:  Guozheng Huang; Simon Schramm; Jörg Heilmann; David Biedermann; Vladimír Křen; Michael Decker
Journal:  Beilstein J Org Chem       Date:  2016-04-08       Impact factor: 2.883

10.  Evaluation of Hepatoprotective Effect of Silymarin Among Under Treatment Tuberculosis Patients: A Randomized Clinical Trial.

Authors:  Majid Marjani; Parvaneh Baghaei; Mehdi Kazempour Dizaji; Pegah Gorji Bayani; Fanak Fahimi; Payam Tabarsi; Ali Akbar Velayati
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.